Cargando…
Cemiplimab as First Line Therapy in Advanced Penile Squamous Cell Carcinoma: A Real-World Experience
In the treatment of cancer, immune checkpoint inhibitors (ICIs) have demonstrated significantly greater effectiveness compared to conventional cytotoxic or platinum-based chemotherapies. To assess the efficacy of ICI’s in penile squamous cell carcinoma (pSCC) we performed a retrospective observation...
Autores principales: | Rouvinov, Keren, Mazor, Gal, Kozlener, Ella, Meirovitz, Amichay, Shrem, Noa Shani, Abu Saleh, Omar, Shalata, Sondos, Yakobson, Alexander, Shalata, Walid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672594/ https://www.ncbi.nlm.nih.gov/pubmed/38003938 http://dx.doi.org/10.3390/jpm13111623 |
Ejemplares similares
-
Dermatomyositis Associated with Lung Cancer: A Brief Review of the Current Literature and Retrospective Single Institution Experience
por: Shalata, Walid, et al.
Publicado: (2022) -
Erdafitinib treatment in metastatic urothelial carcinoma: a real-world analysis
por: Rouvinov, Keren, et al.
Publicado: (2023) -
Unexpected Adverse Events of Immune Checkpoint Inhibitors
por: Shalata, Walid, et al.
Publicado: (2023) -
Long-Lasting Therapeutic Response following Treatment with Pembrolizumab in Patients with Non-Small Cell Lung Cancer: A Real-World Experience
por: Shalata, Walid, et al.
Publicado: (2023) -
Carpal Tunnel Syndrome Associated with Immune Checkpoint Inhibitors
por: Yakobson, Alexander, et al.
Publicado: (2023)